Skip to main content

Aggregator

Alnylam Reports Positive Initial Phase 1b Results For ALN-HTT02

23 hours 50 minutes ago
(RTTNews) - Alnylam Pharmaceuticals (ALNY) reported positive initial Phase 1b clinical trial results for ALN-HTT02, an investigational RNAi therapeutic in development for the treatment of Huntington's disease. ALN-HTT02 will be developed under the International Nonproprietary Nam